Cologne, Germany

Gerhard Dankert

This inventor holds 6 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1977-1981.


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1977-1981

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Gerhard Dankert: Innovator in Chemical Processes

Introduction

Gerhard Dankert is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing complex chemical compounds. With a total of 6 patents to his name, Dankert's work has had a lasting impact on the industry.

Latest Patents

Among his latest patents is a process for the preparation of 2,4,5-trichloropyrimidine. This compound is obtained by reacting 2-cyanoethyl isocyanide dichloride with hydrogen chloride, followed by a reaction with chlorine. Another significant patent involves the preparation of tetrachloropyrimidine, characterized by the reaction of 2-cyanoethyl isocyanide dichloride with chlorine in the gas phase at temperatures ranging from 200°C to 650°C.

Career Highlights

Gerhard Dankert is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His innovative approaches to chemical synthesis have contributed to the advancement of various applications within the industry.

Collaborations

Throughout his career, Dankert has collaborated with esteemed colleagues such as Gunther Beck and Fritz Doring. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Gerhard Dankert's contributions to chemical processes exemplify the spirit of innovation in the field. His patents and collaborations continue to influence the industry, showcasing the importance of research and development in advancing technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…